Google's AI model proposes a novel drug combination for cancer detection, marking a milestone in AI-driven scientific ...
A practical look at the challenges of diagnosing and managing feline hyperthyroidism, from misleading symptoms to complex ...
The American Association of Clinical Endocrinology (AACE) has released its 2025 Consensus Statement, introducing a ...
Despite impressive efficacy across a range of tumour types, their role in activating the immune system results in frequent immune-related adverse events (irAE). While gastrointestinal, endocrine ...
News-Medical.Net on MSN
European societies launch EndoCompass to guide the future of endocrine research
The European Society for Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) have released today ...
Financial stress is costing Canadian employers nearly $70 billion in lost productivity each year. A bold new idea introduced by researchers at Canada’s Financial Wellness Lab based at Western ...
The ICMR-INDIAB survey of 18,090 adults revealed major differences in macronutrient intake across different regions in India. The study demonstrated that replacing dietary carbohydrates with plant and ...
According to a new MIT Media Lab report, a staggering 95 percent of organizations ... content that looks polished but doesn’t actually move work forward." In practice, it means employees end up ...
8don MSN
GLP-1 Drugs for Diabetes and Obesity Show Promise in Treating Alcohol and Drug Addiction: Study
A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug ...
ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...
Transplant experts have urged the EU to pilot clinics for transplant survivors, led by transplant and oncology teams ...
Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results